Grant of Stock Acquisition Rights to Directors and Executive Officers
First written in FY2019-Q2. 8 of 9 entries say "Advanced", first in FY2019-Q3. Latest entry: FY2024-Q3.
106 other companies' latest entry also says "Advanced".
- FY2024-Q3AdvancedAnnual report
「1 October 2023–31 December 2023 (Note) 38 397,083 21 51,362 21 19,709 (Note) Increases resulting from the exercise of stock acquisition rights.」
The exercise of stock acquisition rights increased the number of issued shares by 38 thousand, and capital and capital reserves by ¥21 million each during the third-quarter accounting period. - FY2024-Q2AdvancedAnnual report
「1 July 2023–30 September 2023 (Note) 68 397,045 37 51,340 37 19,688 (Note) Increases resulting from the exercise of stock acquisition rights.」
The exercise of stock acquisition rights increased the number of issued shares by 68 thousand, and capital and capital reserves by ¥37 million each during the second-quarter accounting period. - FY2023-Q2AdvancedAnnual report
「1 July 2022–30 September 2022 (Note) 39 396,794 24 51,198 24 19,546 (Note) Increases resulting from the exercise of stock acquisition rights.」
The exercise of stock acquisition rights increased the number of issued shares by 39 thousand, and capital and capital reserves by ¥24 million each during the second-quarter accounting period. - FY2022-Q1AdvancedAnnual report
- FY2020AdvancedAnnual report
「Following the transition to a company with three committees, from fiscal 2020 we have revised the eligible recipients of each type of remuneration, the annual remuneration standards for each type of remuneration, and the proportion accounted for by each type of remuneration in total remuneration, as follows.」
Following the transition to a company with three committees, the remuneration structure and eligible recipients for directors and executive officers were revised for fiscal 2020. - FY2020-Q3AdvancedAnnual report
「1 October 2019–31 December 2019 (Note) 77 395,972 39 50,719 39 19,067 (Note) Increases resulting from the exercise of stock acquisition rights.」
The exercise of stock acquisition rights during the third-quarter accounting period increased the total number of issued shares by 77 thousand, and capital and capital reserves by ¥39 million each. - FY2020-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second-quarter accounting period were as follows: Isetan Mitsukoshi Holdings Ltd. Series 33 Stock Acquisition Rights (issued by the filing company) … 5 directors and 6 executive officers of the Company … Isetan Mitsukoshi Holdings Ltd. Series 34 Stock Acquisition Rights (issued by the filing company) … 4 directors and 12 executive officers of Isetan Mitsukoshi Ltd.」
The Series 33 and Series 34 Stock Acquisition Rights resolved on 17 June 2019 were issued to the directors and executive officers of the holding company and Isetan Mitsukoshi. - FY2019-Q3AdvancedAnnual report
「1 October 2018–31 December 2018 (Note) 35 395,595 16 50,520 16 18,868 (Note) Increases resulting from the exercise of stock acquisition rights.」
The exercise of stock acquisition rights increased the number of issued shares by 35 thousand, capital by ¥16 million and capital reserves by ¥16 million during the current quarterly accounting period. - FY2019-Q2First statedAnnual report
「Isetan Mitsukoshi Holdings Ltd. Series 31 Stock Acquisition Rights (issued by the filing company) and Isetan Mitsukoshi Holdings Ltd. Series 32 Stock Acquisition Rights (issued by the filing company) have been issued. The eligible grantees for the Series 31 Stock Acquisition Rights are 5 directors and 8 executive officers of the Company, while those for the Series 32 Stock Acquisition Rights are 2 directors and 16 executive officers of Isetan Mitsukoshi Ltd.」
The Series 31 and Series 32 Stock Acquisition Rights resolved on 18 June 2018 were issued to the directors and executive officers of the holding company and Isetan Mitsukoshi. The exercise period for each series is from 1 August 2019 to 3 July 2034.